summary

Doctor Mike Hansen - Covid Breakthrough Cases - Is COVID Vaccine Effective Against DELTA VARIANT?

Thumbnail of the video “Doctor Mike Hansen - Covid Breakthrough Cases - Is COVID Vaccine Effective Against DELTA VARIANT?”
Community upload. AI output has not been independently verified.

Short Summary

Main recommendation: Dr. Hansen explains that vaccines greatly reduce severe COVID illness, hospitalization, and death, even as breakthrough infections, including with the Delta variant, become more common. The speaker stresses that breakthrough cases are rarer and usually milder than infections in the unvaccinated.

Key Points

  • Breakthrough infections are defined as a positive PCR test at least 14 days after full vaccination; the CDC reports 162 million fully vaccinated Americans, under 2% of COVID hospitalizations are vaccinated, and 99.5% of COVID deaths were unvaccinated.
  • Dr. Hansen notes original trials put mRNA vaccine (Pfizer and Moderna) effectiveness at about 95% against severe illness, lower against mild or asymptomatic infection, and cites a study finding the Delta variant, now over 80% of US cases, carries about 1,000 times more virus.
  • Against Delta, a New England Journal of Medicine study found two Pfizer doses gave 88% protection against symptomatic disease (versus 93% against Alpha), and two AstraZeneca doses gave 67%.
  • Dr. Hansen cites a study finding vaccinated people with breakthrough infections had about 40% less virus, were 58% less likely to have a fever, and spent two fewer days in bed than unvaccinated patients.
  • Vaccinated people are less likely to transmit the virus even when asymptomatic, though a 12,000-student Moderna study was ongoing at the time.

Details Worth Noting

  • Concrete instructions: If fully vaccinated and symptomatic, get tested. After a positive test, the CDC advises staying out of public for at least 10 days. If exposed to many people, especially unvaccinated ones, wear a mask; even a regular face covering reduces transmission better than no mask.
  • Vaccine-specific caveats: Moderna data was still pending, with the company saying its vaccine stayed effective against variants. The Johnson & Johnson vaccine may be less effective against Delta and Lambda, with the speaker suggesting recipients may need a Pfizer or Moderna dose, pending publication.
  • Breakthrough cases were reported at the White House, in Congress, at the Olympics, and in Major League Baseball (notably the New York Yankees).
  • Stanford required vaccination for students and faculty before fall return, one of nearly 600 US universities and colleges; seven fully vaccinated Stanford students developed symptomatic COVID within one week.
  • Dr. Hansen cites a study of 3,900 essential workers finding partial vaccination (one dose) was associated with 81% lower infection likelihood, while full vaccination gave over 90% protection.

Bottom Line

Vaccination still substantially lowers the risk of severe illness and transmission, even though the Delta variant makes breakthrough infections possible and vaccines are not 100% effective.

Facts

  1. In a New England Journal of Medicine study, two Pfizer doses gave 88% protection against symptomatic Delta variant disease.

    0:00